PubMed

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin.

Barst RJ, Rubin LJ, McGoon MD, Caldwell EJ, Long WA, Levy PS.

Ann Intern Med. 1994 Sep 15;121(6):409-15.PMID: 8053614 [PubMed - indexed for MEDLINE]Related articlesFree article

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group.

Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH, et al.

N Engl J Med. 1996 Feb 1;334(5):296-302.PMID: 8532025 [PubMed - indexed for MEDLINE]Related articlesFree article

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

Badesch DB, Tapson VF, McGoon MD, Brundage BH, Rubin LJ, Wigley FM, Rich S, Barst RJ, Barrett PS, Kral KM, Jöbsis MM, Loyd JE, Murali S, Frost A, Girgis R, Bourge RC, Ralph DD, Elliott CG, Hill NS, Langleben D, Schilz RJ, McLaughlin VV, Robbins IM, Groves BM, Shapiro S, Medsger TA Jr.

Ann Intern Med. 2000 Mar 21;132(6):425-34.PMID: 10733441 [PubMed - indexed for MEDLINE]Related articlesFree article

[Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension]

Nakayama T, Ishikita T, Matsuura H, Saji T.

J Cardiol. 2001 Nov;38(5):263-71. Japanese. PMID: 11729726 [PubMed - indexed for MEDLINE]Related articles

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial.

Rubin LJ, Mendoza J, Hood M, McGoon M, Barst R, Williams WB, Diehl JH, Crow J, Long W.

Ann Intern Med. 1990 Apr 1;112(7):485-91.PMID: 2107780 [PubMed - indexed for MEDLINE]Related articles

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Hervé P, Rainisio M, Simonneau G.

J Am Coll Cardiol. 2002 Aug 21;40(4):780-8.PMID: 12204511 [PubMed - indexed for MEDLINE]Related articles

Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.

Simonneau G, Rubin LJ, Galiè N, Barst RJ, Fleming TR, Frost AE, Engel PJ, Kramer MR, Burgess G, Collings L, Cossons N, Sitbon O, Badesch DB; PACES Study Group.

Ann Intern Med. 2008 Oct 21;149(8):521-30. Erratum in: Ann Intern Med. 2009 Jan 6;150(1):63. Ann Intern Med. 2009 Sep 15;151(6):435. PMID: 18936500 [PubMed - indexed for MEDLINE]Related articlesFree article

Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series.

McLaughlin VV, Genthner DE, Panella MM, Hess DM, Rich S.

Ann Intern Med. 1999 May 4;130(9):740-3.PMID: 10357693 [PubMed - indexed for MEDLINE]Related articlesFree article

Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study.

Humbert M, Sanchez O, Fartoukh M, Jagot JL, Le Gall C, Sitbon O, Parent F, Simonneau G.

Eur Respir J. 1999 Jun;13(6):1351-6.PMID: 10445611 [PubMed - indexed for MEDLINE]Related articlesFree article

Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.

Cabrol S, Souza R, Jais X, Fadel E, Ali RH, Humbert M, Dartevelle P, Simonneau G, Sitbon O.

J Heart Lung Transplant. 2007 Apr;26(4):357-62.PMID: 17403477 [PubMed - indexed for MEDLINE]Related articles

Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion.

Shapiro SM, Oudiz RJ, Cao T, Romano MA, Beckmann XJ, Georgiou D, Mandayam S, Ginzton LE, Brundage BH.

J Am Coll Cardiol. 1997 Aug;30(2):343-9.PMID: 9247503 [PubMed - indexed for MEDLINE]Related articles

[Ten years' experience in continuous intravenous epoprostenol therapy in severe pulmonary arterial hypertension]

Pombo Jiménez M, Escribano Subías P, Tello de Meneses R, Gómez-Sánchez MA, Delgado Jiménez J, Dalmau González-Gallarza R, Lázaro Salvador M, Hernández Rodríguez I, Tascón Pérez J, Sáenz de la Calzada C.

Rev Esp Cardiol. 2003 Mar;56(3):230-5. Spanish. PMID: 12622952 [PubMed - indexed for MEDLINE]Related articlesFree article

[Long-term experience with trerpostinil infusion treatment in patients with pulmonary arterial hypertension in the Czech Republic]

Jansa P, Ambroz D, Maresová J, Jelínková L, Polácek P, Palecek T, Aschermann M, Linhart A.

Vnitr Lek. 2007 Apr;53(4):333-7. Czech. PMID: 17578162 [PubMed - indexed for MEDLINE]Related articles

Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial.

Galiè N, Humbert M, Vachiéry JL, Vizza CD, Kneussl M, Manes A, Sitbon O, Torbicki A, Delcroix M, Naeije R, Hoeper M, Chaouat A, Morand S, Besse B, Simonneau G; Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group.

J Am Coll Cardiol. 2002 May 1;39(9):1496-502.PMID: 11985913 [PubMed - indexed for MEDLINE]Related articles

Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertension.

Wax D, Garofano R, Barst RJ.

Chest. 1999 Oct;116(4):914-20.PMID: 10531153 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

McLaughlin VV, Genthner DE, Panella MM, Rich S.

N Engl J Med. 1998 Jan 29;338(5):273-7.PMID: 9445406 [PubMed - indexed for MEDLINE]Related articlesFree article

Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.

Olschewski H, Walmrath D, Schermuly R, Ghofrani A, Grimminger F, Seeger W.

Ann Intern Med. 1996 May 1;124(9):820-4.PMID: 8610951 [PubMed - indexed for MEDLINE]Related articlesFree article

Prostanoids for pulmonary arterial hypertension.

Galiè N, Manes A, Branzi A.

Am J Respir Med. 2003;2(2):123-37. Review.PMID: 14720012 [PubMed - indexed for MEDLINE]Related articles

Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.

Oudiz RJ, Schilz RJ, Barst RJ, Galié N, Rich S, Rubin LJ, Simonneau G; Treprostinil Study Group.

Chest. 2004 Aug;126(2):420-7.PMID: 15302727 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects.

Rosenzweig EB, Kerstein D, Barst RJ.

Circulation. 1999 Apr 13;99(14):1858-65.PMID: 10199883 [PubMed - indexed for MEDLINE]Related articlesFree article